Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction.

Autor: Allijn IE; Department of Biomaterials Science and Technology, University of Twente, Enschede, Drienerlolaan 5, 7522 NB Enschede, The Netherlands., Czarny BMS; Department of Pharmacy, National University of Singapore, Science Drive 2, 117543, Singapore; Department of Pharmaceutics, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands., Wang X; Department of Surgery, YLL School of Medicine, National University of Singapore, Singapore; Cardiovascular Research Institute (CVRI), National University Heart Centre Singapore (NUHCS) and National University Health System (NUHS), 117599, Singapore., Chong SY; Department of Surgery, YLL School of Medicine, National University of Singapore, Singapore; Cardiovascular Research Institute (CVRI), National University Heart Centre Singapore (NUHCS) and National University Health System (NUHS), 117599, Singapore., Weiler M; Department of Experimental Molecular Imaging, University Clinic RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany., da Silva AE; Department of Biomaterials Science and Technology, University of Twente, Enschede, Drienerlolaan 5, 7522 NB Enschede, The Netherlands., Metselaar JM; Department of Biomaterials Science and Technology, University of Twente, Enschede, Drienerlolaan 5, 7522 NB Enschede, The Netherlands; Department of Experimental Molecular Imaging, University Clinic RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany., Lam CSP; National Heart Centre Singapore, Singapore General Hospital, Duke-National University, Hospital Drive 5, 169609, Singapore; Department of Cardiology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., Pastorin G; Department of Pharmacy, National University of Singapore, Science Drive 2, 117543, Singapore., de Kleijn DPV; Department of Surgery, YLL School of Medicine, National University of Singapore, Singapore; Vascular Surgery & Experimental Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands; Interuniversity Cardiology Institute of the Netherlands (ICIN), PO Box 19258, 3501 DG Utrecht, The Netherlands., Storm G; Department of Biomaterials Science and Technology, University of Twente, Enschede, Drienerlolaan 5, 7522 NB Enschede, The Netherlands; Department of Pharmaceutics, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands., Wang JW; Department of Surgery, YLL School of Medicine, National University of Singapore, Singapore; Cardiovascular Research Institute (CVRI), National University Heart Centre Singapore (NUHCS) and National University Health System (NUHS), 117599, Singapore. Electronic address: surwang@nus.edu.sg., Schiffelers RM; Clinical Chemistry and Haematology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Electronic address: r.schiffelers@umcutrecht.nl.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2017 Feb 10; Vol. 247, pp. 127-133. Date of Electronic Publication: 2017 Jan 05.